Dana-Farber Cancer Center

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Dana-Farber Cancer Center
Jun 20, 2024, 07:36 | Blog
LGBTQ+ patients report on their cancer care journey
Estela Rodriguez shared a post on X: "Disparities uncovered: LGBTQ+ patients report on their cancer care…
Apr 28, 2024, 21:10 | Drugs
Doug Rubinson: The best drug in GI cancers is 5-FU
Doug Rubinson, GI Medical Oncologist At Dana-Farber Cancer Centre, shared on X/Twitter: "In oncology, we…
Apr 12, 2024, 16:30 | Insight
Douglas Flora: NEJM AI and the team at Dana-Farber Cancer Center just published a great case study in which they revealed some insights following the (careful) deployment of generative AI
Apr 8, 2024, 14:26 | Drugs
Dana-Farber’s Breast Oncology Center is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH
Dana-Farber’s Breast Oncology Center posted on X: "We are leading a randomized Phase 2 trial for…
Mar 27, 2024, 14:24 | Blog
Elad Sharon: A great honor to speak at The Tisch Cancer Institute this week at Hematology Oncology Grand Rounds
Elad Sharon, Clinical and Translational Director at Dana-Farber Cancer Institute, shared a post by The Tisch Cancer Institute,…
Mar 16, 2024, 20:43 | Insight
Humaid Al-Shamsi: Pleased to share with you our latest 2 publications published on the same day about lung cancer
Humaid Al-Shamsi, Director of Burjeel Cancer Institute Comprehensive Cancer Center and Burjeel Holdings Oncology UAE,…
Nov 4, 2023, 00:39 | Opinion
Narjust Florez: Discharge is the time when patients are most vulnerable
Narjust Florez shared in Twitter: "Discharge is the time when patients are most vulnerable. A…
All: 7 Posts: 1 - 10